Literature DB >> 20553679

Potential diagnostic utility of intermittent administration of short-acting gonadotropin-releasing hormone agonist in gonadotropin deficiency.

Carrie A Zimmer1, David A Ehrmann, Robert L Rosenfield.   

Abstract

OBJECTIVE: To determine if intermittent, low-dose, short-acting gonadotropin-releasing hormone agonist (GnRH-agonist) administration sufficiently up-regulates pituitary-gonadal function in gonadotropin deficiency to be of diagnostic or therapeutic value.
DESIGN: Case-control study.
SETTING: General clinical research center. PATIENT(S): Normal adult volunteers and gonadotropin-deficiency patients. INTERVENTION(S): Low-dose leuprolide acetate administered subcutaneously at 4- to 5-day intervals up to 1 year. MAIN OUTCOME MEASURE(S): Levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and sex steroid responses. RESULT(S): In normal men and women, low-dose GnRH-agonist repetitively transiently stimulated gonadotropins in a gender-dimorphic manner. In congenitally gonadotropin-deficient men (n = 6) and women (n = 1), none of whom had a normal LH response to an initial GnRH-agonist test dose, this regimen consistently stimulated LH to the normal baseline range within 2 weeks. Long-term GnRH-agonist administration to a partially gonadotropin-deficient man did not alleviate hypogonadism, however. Women with hypothalamic amenorrhea (n = 2) responded normally to a single GnRH-agonist injection; however, repeated dosing did not seem to induce the normal priming effect. CONCLUSION(S): The subnormal LH response to GnRH-agonist in patients with congenital gonadotropin deficiency normalized in response to repetitive intermittent GnRH-agonist administration but not sufficiently to improve hypogonadism. Hypothalamic amenorrhea patients lacked the priming response to repeated GnRH-agonist but otherwise had normal hormonal responses to GnRH-agonist. We conclude that intermittent administration of a short-acting GnRH-agonist is of potential diagnostic value in distinguishing hypothalamic from pituitary causes of gonadotropin deficiency.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553679      PMCID: PMC2944005          DOI: 10.1016/j.fertnstert.2010.04.019

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  27 in total

1.  Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty.

Authors:  Dyanne A Wilson; P L Hofman; H L Miles; K E Unwin; C E McGrail; Wayne S Cutfield
Journal:  J Pediatr       Date:  2006-01       Impact factor: 4.406

2.  Functional significance of polycystic-size ovaries in healthy adolescents.

Authors:  Monica Mortensen; Robert L Rosenfield; Elizabeth Littlejohn
Journal:  J Clin Endocrinol Metab       Date:  2006-08-08       Impact factor: 5.958

3.  KAL1 mutations are not a common cause of idiopathic hypogonadotrophic hypogonadism in humans.

Authors:  Balasubramanian Bhagavath; Ning Xu; Metin Ozata; Robert L Rosenfield; David P Bick; Richard J Sherins; Lawrence C Layman
Journal:  Mol Hum Reprod       Date:  2007-01-09       Impact factor: 4.025

4.  Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study.

Authors:  R L Rosenfield; N Perovic; D A Ehrmann; R B Barnes
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

Review 5.  Gonadotropin-releasing hormone and its analogs.

Authors:  P M Conn; W F Crowley
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

6.  Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys--a clinical research center study.

Authors:  K Ghai; J F Cara; R L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  1995-10       Impact factor: 5.958

7.  Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men.

Authors:  J S Finkelstein; R W Whitcomb; L S O'Dea; C Longcope; D A Schoenfeld; W F Crowley
Journal:  J Clin Endocrinol Metab       Date:  1991-09       Impact factor: 5.958

8.  Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men.

Authors:  Nelly Pitteloud; Andrew A Dwyer; Suzzunne DeCruz; Hang Lee; Paul A Boepple; William F Crowley; Frances J Hayes
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

9.  Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.

Authors:  R L Rosenfield; R B Barnes; D A Ehrmann
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

10.  A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies.

Authors:  D A Ehrmann; R L Rosenfield; L Cuttler; S Burstein; J F Cara; L L Levitsky
Journal:  J Clin Endocrinol Metab       Date:  1989-11       Impact factor: 5.958

View more
  7 in total

Review 1.  Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity.

Authors:  Robert L Rosenfield; Brian Bordini
Journal:  Brain Res       Date:  2010-09-25       Impact factor: 3.252

2.  The Effect of the Testis on the Ovary: Structure-Function Relationships in a Neonate with a Unilateral Ovotestis (Ovotesticular Disorder of Sex Development)
.

Authors:  Siri Atma W Greeley; Elizabeth Littlejohn; Aliya N Husain; Darrel Waggoner; Mohan Gundeti; Robert L Rosenfield
Journal:  Horm Res Paediatr       Date:  2017-03-02       Impact factor: 2.852

Review 3.  Case Report: Hypothalamic Amenorrhea Following COVID-19 Infection and Review of Literatures.

Authors:  Paolo Facondo; Virginia Maltese; Andrea Delbarba; Ilenia Pirola; Mario Rotondi; Alberto Ferlin; Carlo Cappelli
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

4.  Comparison of detection of normal puberty in girls by a hormonal sleep test and a gonadotropin-releasing hormone agonist test.

Authors:  Robert L Rosenfield; Brian Bordini; Christine Yu
Journal:  J Clin Endocrinol Metab       Date:  2013-03-01       Impact factor: 5.958

Review 5.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

6.  Comparison of detection of normal puberty in boys by a hormonal sleep test and a gonadotropin-releasing hormone agonist test.

Authors:  Robert L Rosenfield; Brian Bordini; Christine Yu
Journal:  J Clin Endocrinol Metab       Date:  2012-10-05       Impact factor: 5.958

Review 7.  Clinical review: Adolescent anovulation: maturational mechanisms and implications.

Authors:  Robert L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  2013-08-02       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.